MetaADEDB 2.0 @ LMMD
Thioctic Acid
(AGBQKNBQESQNJD-UHFFFAOYSA-N)
Structure
SMILES
OC(=O)CCCCC1SSCC1
Molecular Formula:
C8H14O2S2
Molecular Weight:
206.326
Log P:
2.7851
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
1
TPSA:
87.9
CAS Number(s):
62-46-4; 1077-28-7
Synonym(s)
1.
Thioctic Acid
2.
Lipoic Acid
3.
Alpha-Lipogamma
4.
Alpha-Lipon Stada
5.
Alpha-Liponsaure Sofotec
6.
Alpha-Lippon AL
7.
Alphaflam
8.
Azulipont
9.
Fenint
10.
Juthiac
11.
Liponsaure-ratiopharm
12.
MTW-Alphaliponsaure
13.
Neurium
14.
Pleomix-Alpha
15.
Pleomix-Alpha N
16.
Thioctacid
17.
Thioctacide T
18.
Thiogamma Injekt
19.
Thiogamma oral
20.
Tromlipon
21.
Verla-Lipon
22.
alpha-Lipoic Acid
23.
alpha-Liponaure Heumann
24.
alpha-Liponsaure von ct
25.
alpha-Vibolex
26.
biomo-lipon
27.
duralipon
28.
espa-lipon
29.
Acid, alpha-Lipoic
30.
Alpha Lipogamma
31.
Alpha Lipon Stada
32.
Alpha Liponsaure Sofotec
33.
Alpha Lippon AL
34.
AlphaLipogamma
35.
AlphaLipon Stada
36.
AlphaLiponsaure Sofotec
37.
AlphaLippon AL
38.
Injekt, Thiogamma
39.
Liponsaure ratiopharm
40.
Liponsaureratiopharm
41.
MTW Alphaliponsaure
42.
MTWAlphaliponsaure
43.
Pleomix Alpha
44.
Pleomix Alpha N
45.
PleomixAlpha
46.
PleomixAlpha N
47.
Verla Lipon
48.
VerlaLipon
49.
alpha Lipoic Acid
50.
alpha Liponaure Heumann
51.
alpha Liponsaure von ct
52.
alpha Vibolex
53.
alphaLiponaure Heumann
54.
alphaLiponsaure von ct
55.
alphaVibolex
56.
biomo lipon
57.
biomolipon
58.
espa lipon
59.
espalipon
External Link(s)
MeSHD008063
PubChem Compound864
BindingDB10515
ChEBI16494
CHEMBLCHEMBL33864
DrugCentral4732
KEGGdr:D00086
cpd:C00725
Therapeutic Target DatabaseD0P6PQ
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Blood glucose increasedFAERS: 1US FAERS
2Rectal abscessFAERS: 1US FAERS
3Abdominal discomfortCanada Vigilance: 1Canada Vigilance
4Acute kidney injury15526909CTD
5Asthenozoospermia28880400CTD
6Brain Diseases20490610CTD
7Brain Infarction14512146CTD
8Brain Injuries19715735
21062633
CTD
9Carcinoma, Lewis Lung21655919CTD
10Catalepsy19444377CTD
11Cataract20597648CTD
12Chemical and Drug Induced Liver Injury18068886
29760339
CTD
13Cognition Disorders19669875CTD
14Diabetic Angiopathies17970755CTD
15Diabetic Cardiomyopathies19951573CTD
16Diabetic Neuropathies7587852
21092474
CTD
17Diarrhea19900424
26276312
CTD
18Edema19735303CTD
19Hyperammonemia23880158CTD
20Hyperinsulinism22664981CTD
21Inflammation19735303
21251946
CTD
22Insulin Resistance22464149CTD
23Intestinal Diseases19900424CTD
24Kidney Diseases16236146
18068886
21763304
CTD
25Liver Cirrhosis21251946
29760339
CTD
26Liver Neoplasms, Experimental21786683
23830814
CTD
27Long QT Syndrome23474023CTD
28Mitochondrial Diseases20414966CTD
29Movement Disorders19444377CTD
30Nerve Degeneration18809400CTD
31Non-alcoholic Fatty Liver Disease22327056
22464149
CTD
32Oligospermia28880400
29214690
CTD
33Peripheral Nervous System Diseases18809400CTD
34Prenatal Exposure Delayed Effects28070105CTD
35Product physical issueCanada Vigilance: 1Canada Vigilance
36Retinitis Pigmentosa16849425CTD
37Seizures

View details

CTD
38Teratozoospermia28880400CTD
39Testicular Diseases21195065
27581792
29214690
CTD
40Throat irritationCanada Vigilance: 1Canada Vigilance
41Weight Gain

View details

CTD
42melanoma21655919CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120141

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.